Victrix Computational Chemistry and Medicinal Chemistry Consultancy
Contact us
  • Home
  • Philosophy
  • Services
  • Our Clients
  • Contact
  • About
    • Press Releases
  • Victrix Sounds Off
  • Blog

On pathologizing symptoms of a broken society.

7/22/2013

1 Comment

 
Picture
So I am now mildly annoyed.  This advertisement for Nuvigil (a stimulant that has legitimate uses for narcolepsy indicates that if you have a patient that is overworked (go to the site there are other examples where the answer to the condition is for the employers of said individuals to let them lead normal lives) don't tell them to rest and listen to their bodies, give them Nuvigil! 

I get very nervous when I see things like this.  I've been fortunate enough in my career to only work on important problems: cancer, cancer adjuvant therapy, inflammatory disease, severe neuropathic pain, and degenerative neurologic disorders.  I would be very unhappy if my labor were being used to drug overworked  people into ignoring their circadian rhythms. 

Our society is broken.  Now we are beginning to turn to drugs to (I guess people have always self medicated with alcohol) deal with societal problems that should be dealt with at societal level. I personally am against the Affordable Healthcare act.  Not because of what it does, because of what it does not.  We are at a point in the development of our civilization where we should care enough about our fellows that we do not allow someone to die if we can do something about it.  It is something that is too important to be left to private industry.  Drug discovery is something too important to be left to government.  We should have a national health care like every other developed nation. 

 I love the pharmaceutical industry.  It has given me an interesting life where I could work on interesting problems.  I love it so much that I think there should be many more companies.  Lets do an AT&T like break up on the big pharmaceutical companies and return to the state of the 1980's when Merck was respected and innovative and GSK was Glaxo, Smith-Kilne and Beecham. 

Here endeth the lesson.

1 Comment
Daniel link
10/29/2014 08:31:19 pm

your comments are severely biased; I assume that you have not had the pleasure of being a dedicated night shift staff member; perhaps residency has been your only viable option. I have been working night shift 1800-0630 for over 10 years now and due to family life have not been able to adjust my sleep cycle accordingly. I have only been on nuvigil for maybe a week now and honestly don't have very many expectations of this medication and only take it as needed due to shift work disorder. Practitioners that are judgmental are not looking out for the best interest of their patients therefore I'm sure that you are a poor listener or conversationalist. The time it has taken me to write this has surely been a waste but I appreciate the opportunity; I hope that you will not be so ignorant of your patients needs in the future; thanks for your opinions on this matter!

Reply



Leave a Reply.

    Adam Kallel Ph. D.

    Our CSO sounds off about drug discovery, computational chemistry and history

    Archives

    March 2014
    January 2014
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013

    Categories

    All
    Ageing
    Amphetamine
    Anti-virals
    Biography
    Broken Society
    Caffeine
    Cancer
    Cd26
    Cluster Headache
    Colic
    Collaboration
    Corona Virus
    Danger Danger
    Depression
    Drug Discovery
    Drug Resistence
    Economy Of Scale
    Electron Microscopy
    Emergent Infectious Disease
    Encephalitis Lethargica
    Global Epidemiology
    Goal Setting
    HCoV-EMC
    Hiring
    Incorrect Pathologizing
    Incretin
    Influenza
    Jobs
    Me
    Merck
    Mergers
    Metabolic Disease
    Migraine
    Nerd
    Neurotransmiters
    Open Positions
    Over Prescription
    Overwork
    Pharma
    Pharmaceutical Industry
    Restructuring
    Stimulants
    Telomerase
    Tuberculosis
    Viral Replication
    Virus

    RSS Feed

    comments powered by Disqus
    View my profile on LinkedIn